Alemtuzumab Reactions 1680, p22 - 2 Dec 2017 Drug eruption and lymphopenia: case report A 32-year-old woman developed drug eruption and lymphopenia during treatment with alemtuzumab [route and dosage not sated]. The woman, who had a history of multiple sclerosis, started receiving treatment with alemtuzumab for three days as per the protocol. After 10 days of initiation of alemtuzumab, she experienced a widespread rash. Laboratory tests showed elevated CRP (67 mg/L) and lymphopenia (lymphocytes 0.2 × 10 /L) which is an expected adverse effect of alemtuzumab. A diagnosis of a drug eruption secondary to alemtuzumab was made. The authors considered drug eruption to be serious. The woman started receiving treatment with steroids and prednisolone. She responded well to the treatment. She recovered completely, and 12 months later, she received different treatment. The treatment with alemtuzumab was restarted. She again developed skin erythema on her forearms and thighs, which resolved immediately. Author comment: "[T]his case of a severe blistering drug eruption secondary to alemtuzumab in a patient who also had a successful re-exposure, is the first reported." Ngu S, et al. A case of severe drug reaction secondary to alemtuzumab with successful re-exposure. Clinical and Experimental Dermatology 42: 925-926, No. 8, Dec 2017. Available from: URL: - United Kingdom 803284975 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial